Focal Shock Wave Therapy (f-ESWT) for Pain

What f-ESWT Is

Focal shock wave therapy — known by the acronym f-ESWT (focal Extracorporeal Shock Wave Therapy) — uses high-energy acoustic pressure waves focused at a specific point in the tissue. Unlike other shock-wave modalities, the f-ESWT energy beam concentrates its energy in a small target zone, typically on the order of 6 to 8 mm³, allowing deep, precise treatment of structures such as tendon entheses, calcifications, and localized painful foci.

There are three wave-generation technologies, with distinct technical features: electromagnetic (EM), currently the most widespread in modern equipment, with good reproducibility and a broad energy spectrum; electrohydraulic (EH), the original technology — used in renal lithotripsy since the 1980s — today less employed in musculoskeletal practice owing to greater pulse-to-pulse variability; and piezoelectric (PE), the most precise in terms of focusing, with lower maximum power, used in indications that require a well-delimited treatment zone.

It is important to distinguish f-ESWT from radial shock waves (r-ESWT). r-ESWT generates a wave that dissipates radially from the application point, with maximum energy at the surface and progressive attenuation in depth — it is an essentially superficial modality. f-ESWT, by contrast, reaches depths of up to 12 cm with point focus, concentrating energy in a deep plane. The difference is not merely technical: indications, parameters, and expected results differ. The key f-ESWT parameter is energy flux density, expressed in mJ/mm²: low (< 0.10), medium (0.10-0.30), and high (> 0.30), chosen according to the target tissue and condition treated.

Mechanism of Action

The effects of f-ESWT arise not from a single mechanism but from a biological cascade combining controlled microtrauma, a regenerative response, and direct neural modulation. The initial physical event is the passage of the high-pressure pulse through tissue, generating cavitation — formation and abrupt collapse of microbubbles in the interstitial fluid. This phenomenon produces controlled tissue microtrauma, deliberately sublesional, which acts as a trigger for the tissue-healing cascade.

In response to the microstimulus, there is local release of growth factors: VEGF (vascular endothelial growth factor), TGF-β (transforming growth factor beta), BMP-2 (bone morphogenetic protein), and FGF. This signaling induces angiogenesis and neovascularization — formation of new capillaries in areas of chronic tendinopathy, where tissue is usually in a hypovascular, degenerative state. The result, observed in histologic studies, is the progressive replacement of degenerated tendon tissue by more organized matrix.

In parallel, the acoustic pulse exerts a direct analgesic effect through selective denervation of unmyelinated nociceptive fibers (C fibers) and small myelinated fibers (Aδ) — a mechanism that explains the relatively rapid pain relief, often before complete tissue remodeling. In tendon calcifications, a direct mechanical effect on the hydroxyapatite deposit is also added: acoustic energy fragments and contributes to progressive dissolution of the calcification, an effect documented by imaging in calcific tendinopathy of the shoulder.

The combination of these mechanisms — tissue, neural, and, in specific indications, direct mechanical — is what sets f-ESWT apart from other analgesic modalities. It is not merely a symptomatic-relief technique: the therapeutic intent includes structural modification of the target tissue, particularly in chronic tendinopathies with established histologic alteration.

Evidence by Condition

f-ESWT is one of the pain-medicine modalities with the most condition-specific evidence — it is not reasonable to speak of "shock waves working" as a generalization. For some indications, the literature has accumulated robust evidence and international guidelines recognize the technique as an established option; for others, data are limited or absent. An honest reading requires separating indication by indication.

In chronic plantar fasciitis, the meta-analysis by Aqil et al. (2013) aggregated moderate-to-high-quality RCTs and estimated a substantial clinical effect, with standardized mean difference (SMD) of -0.78 (95% CI -1.17 to -0.39) in favor of f-ESWT versus control. This effect size is clinically relevant and relatively consistent across studies with more than 6 months of chronicity. The technique is included among the recognized therapeutic options in international orthopedic guidelines for plantar fasciitis refractory to initial conservative treatment.

In calcific tendinopathy of the shoulder, the evidence is particularly robust. Systematic reviews — including Bannuru et al. — document partial or complete resolution rates of the hydroxyapatite deposit between 60 and 80% after high-energy protocol, with significant pain reduction and functional gain. The combination of direct mechanical effect on the calcification and tissue regenerative stimulus explains the magnitude of benefit. The technique is endorsed by the AAOS (American Academy of Orthopaedic Surgeons) and by ESBOT (European Society for Surgery of the Shoulder and Elbow / European Society for Medical Musculoskeletal Interventions) as an established option in this indication.

In chronic lateral epicondylitis ("tennis elbow"), the evidence is of moderate quality. Pooled RCTs point to an NNT (number needed to treat) between 4 and 6, with more consistent benefit in cases > 6 months refractory to physical therapy and initial conservative treatment. In chronic patellar tendinopathy ("jumper's knee"), small RCTs show positive results but with limited samples — moderate evidence, consistent with use after failed structured eccentric exercise. In Achilles tendinopathy, data are mixed: moderate-to-low result, generally inferior to the documented benefit of the Alfredson eccentric exercise program, which remains as a first-line intervention.

In fracture nonunion (pseudarthrosis), f-ESWT has high-quality evidence in orthopedic studies, with consolidation rates above 70% in selected hypertrophic nonunions — an indication endorsed by orthopedic surgery societies in multiple countries. On the other hand, in generalized myofascial pain, fibromyalgia, and diffuse non-focal pain syndromes, evidence is insufficient or absent, and the technique has no established indication; the literature in this group is composed of small, heterogeneous studies without adequate control groups.

An important gap is the absence of large multicenter RCTs in mixed syndromes — conditions in which focal tendinopathy and a regional myofascial component coexist, a common clinical scenario. Current guidelines reflect this asymmetry: strong support in well-delimited indications and cautious recommendations (or silence) in combined presentations.

Indications

f-ESWT indications are defined by two main variables: chronicity (typically > 3-6 months of persistent symptoms) and failure of adequate initial conservative treatment (structured physical therapy, condition-specific exercise, pertinent pharmacologic management). None of the indications below is first-line — f-ESWT occupies a second- or third-line position in practically all conditions, after attempting modalities with more consolidated evidence for each condition.

How It Is Performed and What to Expect

The f-ESWT session is performed in an office or physical medicine center, with the patient positioned to comfortably expose the region to be treated. After identifying the target point — by clinical palpation, ultrasound guidance, or, in specific indications, fluoroscopy — an acoustic coupling gel is applied to ensure adequate wave transmission. The transducer is positioned on the skin and energy is delivered in repeated pulses.

Typical session parameters vary according to condition and tissue: 2000 to 3000 pulses per session, energy flux density between 0.15 and 0.40 mJ/mm², pulse frequency of 4 to 8 Hz. Deeper tissues and calcifications accept higher energy; superficial areas or tendons with greater sensitivity require an intermediate dose. Application is typically ultrasound-guided in indications dependent on precise localization (calcific tendinopathy, plantar fasciitis at the fascia insertion), which contributes to reproducibility and safety.

Each session lasts on average 15 to 30 minutes. Discomfort during application is frequent — described as a sensation of rhythmic tapping over the region — and varies according to the energy used and individual sensitivity. In selected cases (especially extensive calcifications or patients with reduced tolerance), local anesthesia along the path may be considered. The standard protocol includes 3 to 5 sessions, with weekly or biweekly intervals, and clinical reassessment between 8 and 12 weeks after the last session, the window in which the biological response (angiogenesis, tissue remodeling) consolidates.

An essential operational point: f-ESWT does not replace rehabilitation. The most consistent benefit documented in practice occurs when the technique is part of a program that includes condition-specific exercise (eccentric for lower-limb tendinopathy, specific stretching for plantar fascia, load reeducation by modality). Applied in isolation — without an associated rehabilitation plan — f-ESWT produces inferior results and, in many cases, symptomatic recurrence after the session series.

Adverse Effects, Risks, and Contraindications

f-ESWT presents a favorable safety profile in trained hands, with very rare serious adverse events. However, the technique uses high acoustic energy and has well-defined absolute contraindications that should be rigorously checked before each session. A specific risk — tendon rupture in acute reactive tendinopathy — is important enough to merit particular attention at the time of indication.

Special attention to the reactive phase: applying f-ESWT in recent tendinopathy (< 6 weeks) is one of the most relevant clinical errors. In this phase, tissue is still in inflammatory response — acoustic energy triggers a regenerative cascade on inflamed substrate, which can worsen the condition and, in rare cases, precipitate tendon rupture. The practical rule is clear: if tendinopathy has less than 6 weeks of evolution, f-ESWT is not indicated — management is anti-inflammatory, load control, and waiting for the transition to chronic phase before considering the technique.

Pregnancy and open epiphyses: pregnancy is an absolute contraindication in any trimester, regardless of application site, on a precautionary principle. In children and adolescents with open growth epiphyses, application over growth cartilage is formally contraindicated owing to the potential for interference with bone development; applications over other tissues should be evaluated case by case by a specialist with pediatric experience.

Limitations and What Is Still Not Known

Despite robust evidence in specific indications, f-ESWT faces relevant methodologic and practical limitations. Clinical enthusiasm — legitimate in calcific tendinopathy and plantar fasciitis — should not extend by analogy to all pain syndromes. The main points are below.

Central Gaps

Non-standardized parameters across manufacturers. Energy flux density, pulse count, interval between sessions, and total session count vary significantly across equipment (electromagnetic, electrohydraulic, piezoelectric) and across protocols at different centers. This heterogeneity limits the transferability of published results and hampers robust meta-analyses outside very well-delimited indications.

Few RCTs comparing f-ESWT vs r-ESWT directly. Despite broad clinical use of both modalities, head-to-head comparisons in specific conditions are limited. The choice between focal and radial tends to rest on theoretical considerations (target depth, tissue type) and center experience, rather than on direct high-quality comparative evidence.

Efficacy in mixed syndromes little studied. Real-world conditions frequently combine focal tendinopathy with a regional myofascial component, biomechanical alterations, occupational overload, and a central sensitization component. RCTs in populations with isolated diagnoses do not capture these mixed scenarios, and the literature is scarce on outcomes in combined presentations.

Limited cost and access. f-ESWT equipment is expensive, and the technique requires specific training. In public health systems, availability is typically rare outside university centers and reference services. In private insurance, coverage varies by operator — frequently requires prior authorization. In private practice, the offer is concentrated in clinics specialized in musculoskeletal or orthopedic medicine, with moderate-to-high per-session cost. This operational reality influences both clinical decision and practical viability for the patient.

Relationship with Medical Acupuncture

f-ESWT and medical acupuncture operate by fundamentally different mechanisms. f-ESWT acts predominantly on the mechanical-tissue plane: controlled microtrauma, cavitation, growth-factor release, and local remodeling. Medical acupuncture acts on the neuromodulatory plane: activation of Aδ and C fibers, presynaptic inhibition via gate control, release of endogenous opioids, modulation of the descending inhibitory pathway. Biological targets are distinct, and response profiles reflect this difference.

In clinical practice, this means that the two techniques can be sequential or complementary, but they are not interchangeable. In calcific tendinopathy of the shoulder or refractory chronic plantar fasciitis, f-ESWT has clear advantage owing to its capacity to modify the tissue substrate. In myofascial pain, primary chronic low back pain, or headache, medical acupuncture has superior evidence. Intelligent combination — for example, f-ESWT for the structural lesion (enthesis, calcific tendinopathy) and acupuncture for the associated regional myofascial component — is frequently more effective than any isolated technique.

An important operational point: f-ESWT and acupuncture should not be combined in the same area, in the same session, without an interval. Acoustic energy on tissue that has just received needling (or vice versa) can amplify the local inflammatory response in an unpredictable way. The practical recommendation is to separate the modalities by at least 24 to 48 hours when applied to the same region, or to alternate by distinct anatomic areas in the same session.

In selected contexts, there is specific literature on combining shock waves with dry needling for myofascial pain (see our dedicated article on the f-ESWT + dry needling combination), with interesting results in resistant trigger points — provided the technical interval between interventions is respected. The decision to combine or sequence the techniques should arise from structured medical evaluation and an individualized plan.

When to Seek Medical Help

Deciding to evaluate f-ESWT starts with a structured medical consultation including diagnostic characterization of pain and review of conservative treatment already tried. Seeking the technique without a clear indication tends to lead to frustration: applications outside established indications do not reproduce the robust evidence seen in calcific tendinopathy or plantar fasciitis.